Cancer’s Hidden Cost: How Oncology Must Rethink Toxicity Monitoring
Modern cancer drugs extend survival, but oncology's toxicity monitoring systems—designed for acute effects during treatment—fail to detect and manage late-emerging…
Editor's Top Picks
WHO Breast Cancer Survival Targets: New Global Benchmarks Reveal Progress and Persistent Inequities
New benchmark estimates from Nature Medicine (2026) show breast cancer five-year survival rates across all 194 WHO Member States, revealing…
Submit Your Paper to GMJ
AI-Driven Depression Treatment Platform Neumora Halts Clinical Development
Neumora, an AI-focused depression treatment platform backed by venture capital firm ARCH, has halted its clinical development program. The closure…
How one biotech startup transformed clinical trial failure into an AI-powered health technology breakthrough
A biotech startup has converted data from a failed clinical trial into an artificial intelligence model with potential clinical applications.…
The Hidden Cost of Secrecy: How Missing Research Data Undermines Clinical Guidance
Systematic reviews and meta-analyses that guide clinical practice are increasingly compromised by lack of access to underlying research data, forcing…
Corrected Global Data on Substance Use Burden Across 204 Countries Reveals Shifting Patterns
Nature Medicine has published a corrected Global Burden of Disease assessment of substance use disorders across 204 countries from 1990…
Engineered Heart Muscle From Stem Cells Shows Promise in First-in-Human Trial
A first-in-human clinical trial of engineered heart muscle derived from induced pluripotent stem cells has demonstrated early therapeutic benefit in…
Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Treatment
A new analysis of treatment patterns shows that many patients who discontinue GLP-1 receptor agonists for type 2 diabetes eventually…
Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes
A real-world analysis of 60,000 adults with type 2 diabetes shows semaglutide users experienced 15% fewer bone fractures than those…
Silent spread of chronic wasting disease raises cross-species transmission concerns
Researchers have found that chronic wasting disease can spread silently through asymptomatic animals carrying infectious prions. While no human infections…